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coronary heart disease, diabetes, hyperlipidemia, smoking and
drinking to the inﬂuence factors of ventricular instantly pacing
threshold; Women, age, diabetes, alcohol as the inﬂuence factors of
ventricular 5-10 minutes pacing threshold; Coronary heart disease,
smoking as the inﬂuence factors of atrial pacing immediately
threshold;Diabetes, smoking,5-10 minutes for atrial pacing threshold
of inﬂuencing factors.
2. Different time of myocardial enzyme levels. MYO difference of
preoperative and postoperative different time have statistically sig-
niﬁcance (F¼36.196, P<0.001);CK difference of preoperative and
postoperative different time is statistically signiﬁcant (F¼39.075,
P<0.001);CK – MB difference of preoperative and postoperative
different time is statistically signiﬁcant (F¼11.469, P<0.001);LDH
difference of preoperative and postoperative different time is statis-
tically signiﬁcant (F¼25.430). CTnI concentration pacemaker preop-
erative and postoperative different time difference had statistical
signiﬁcance (F¼21.456, P<21.456).
3. Myocardial enzyme levels, different groups are compared The
myocardial enzyme concentration comparing differences between
single and two pacing leads group had no statistical signiﬁcance.
CONCLUSIONS This study shows that: female, age, smoking, drink-
ing, coronary heart disease, diabetes, hyperlipidemia, heart pace-
makers is active ﬁxed pacing lead in the short term after implantation
of pacing threshold values of independent factors. Myocardial enzyme
level differences of active pacing leads planted before and in different
time after operation were statistically signiﬁcant. There was no sta-
tistically signiﬁcant difference of myocardial enzyme levels implanted
active ﬁxed pacing lead between single and two leads group (P > 0.05).
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OBJECTIVES To assess the efﬁcacy and safety of low-dose b-blocker
for the treatment of three types of vasovagal syncope.
METHODS Sixty-eight consecutive patients (23 males and45 fema-
les;age 3612y) with vasovagal syncope conﬁrmed by head upright tilt
testing (HUTT) from June, 2010 to September, 2014 were enrolled,
including 18 patients of vasodepressive type (VD), 21 patients of car-
dioinhibitory type (CI), and 29 patients of mixed type. Oral b-blocker
with a dosage of 23.75 mg/day was given to each patients. The fre-
quency of syncope, negative conversion rate of HUTT, and potential
adverse reactions (heart50bpm, blood pressure85/60mmHg, or
obviously weakness) were recorded at the follow-up of 1, 3, 6 and 12
months. The efﬁcacy of treatment is deﬁned as either a  50%
reduction of syncope attacks or a negative conversion of HUTT.
RESULTS For all patients, the effective rates signiﬁcantly increased
alongwith the follow-up time (30.88% vs. 42.65% vs. 64.71% vs. 69.12%
at 1, 3, 6 and 12 months respectively, p<0.05). At the 1st month follow-
up, there was no signiﬁcant difference of the effective rates among
three types of vasovagal syncope (27.77% vs. 33.33% vs. 31.03%,
p>0.05). However, CI patients had higher effective rates than VD and
mixed patients at the follow-up of 3 months (52.38% vs. 44.44% vs.
34.48% respectively, p<0.05), 6 months ( 76.19% vs. 61.11% vs. 58.62%
respectively, p<0.01) and 12 months (85.71% vs. 61.11% vs. 62.07%
respectively, p<0.01). No adverse reactionwas recorded for all patients.
CONCLUSIONS Low-dose b-blocker is effective and safe for the
treatment of vasovagal syncope. Compared to VD and mixed patients,
CI patients seem to get more beneﬁts from a long-term treatment due
to the differences of pathogenesis.
GW26-e0685
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OBJECTIVES To summarize the experience and outcomes of radio-
frequency catheter ablation (RFCA) of accessory pathways connecting
the right atrial appendage (RAA) and right ventricle (RV) in our center.METHODS We reviewed all the adult (14 years) 489 cases of supra-
ventricular tachycardia due to accessory pathways (AP) from Jan 2011
to Dec 2013. Two patients were diagnosed to have APs connecting the
RAA and RV through electrophysiological study (EPS) and accepted
RFCA in 2011. We reviewed their surface ECGs and EPS courses, and
summarized their electrophysiological features.
RESULTS The 2 patients were 17 years old (female) and 20years old
(male), respectively. One patient had received a failed RFCA proce-
dure in another center before he was referred to us. None of them
suffered syncope and pre-syncope before EPS. Both patients had a
type B WPW pattern of surface ECG with positive delta waves in lead I,
avL and V1. One patient’s delta wave in inferior leads (II, III, avF) were
positive. The other patient’s delta wave were positive in lead II and
avF, while ﬂat in lead III. Their EPS conﬁrmed that the APs located on
the right side. We failed to eliminate the delta waves and V-A con-
ductions via APs on the earliest A wave on the tricuspid annuli (TA) at
the ﬁrst attempts. We then mapped diffusely in the right atria and got
the earliest retrograde A waves in the RAA, one on the lower portion of
RAA free wall with small V wave (V/A<1), the other on the higher
portion of RAA base with barely visible V wave. RFCA broke the APs
successfully in the RAAs. Both patients have remained symptomless
after RFCA in our center with normal surface ECG pattern.
CONCLUSIONS The atrial end of APs can exist in other than the atrio-
ventricular annulus, such as RAA, which makes ablation challenging.
RFCA can cure these patients successfully with exquisite mapping.
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OBJECTIVES Catecholaminergic polymorphic ventricular tachycardia
(CPVT) is a rare lethal disorder among inherited arrhythmogenic
channelopathies, and would be misdiagnosed by neurologists for the
analogous symptom of syncope. We aim to describe a long-term
misdiagnosis case of CPVT as epilepsy caused by ryanodine receptor 2
gene (RyR2) mutation.
METHODS Clinical data of the patient was collected and analyzed, and
the candidate gene screening was performed by direct sequencing.
RESULTS An 11-year-old male presented with syncope accompanied
with paroxysmal convulsion mainly induced by excise since age 3. He
was diagnosed with epilepsy in several local hospital, but had poor
therapeutic effect of antiepileptic drugs and surgery. When he was
admitted to our hospital, a series of heart-related clinical examina-
tions were performed and showed negative. The electroencephalo-
gram revealed unspeciﬁc as well. However, the bidirectional and
polymorphic ventricular tachycardia was captured via exercise testing
and a RyR2 gene mutation (c.7202G>A, p.R2401H) was identiﬁed by
genetic testing. After taking a high dose of b-adrenergic blocker
(metoprolol succinate sustained-release tablet), the patient has been
free from attacks of syncope for 1 year of follow-up.
CONCLUSIONS The phenotype of syncope together with multiple
ventricular arrhythmias on exercise ECG and a RyR2 mutation sug-
gested that the boy suffers from CPVT. CPVT might be difﬁcult to
distinguish from epilepsy due to the normal heart structure and
resting electrocardiogram of patients, especially for neurologists
knowing less about the disease. Speciﬁc electrocardiographic and
genetic testing should be considered for early diagnosis and treatment
to the prevention of sudden death.
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Observation of active lead performance during permanent direct His
Bundle pacing
Jiaojiao Tang, Silin Chen
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OBJECTIVES To evaluate left ventricular systolic synchronization
during permanent direct His Bundle pacing.
METHODS A total of 42 patients who met class I or class IIa indications
for device-based therapy of cardiac rhythm abnormalities were
enrolled and randomly assigned to perform either direct His Bundle
pacing (DHBP) or right ventricular apical pacing (RVA). A quadrupolar
electrophysiology catheter was advanced to locate His bundle and a
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Regular follow up was performed and pacing parameters were studied
during the time spot of three month after pacemaker implantation.
RESULTS Two patients the DHBP group were then conﬁrmed to be
para His bundle pacing with the evidence of longer QRS duration,
distinct QRS morphology of ECG, and shortening of QRS duration
under high output. Eighteen patients of DHBP group and twenty-two
of RVA group were ﬁnally compared. Pacing threshold in DHBP group
was 0.900.57 V and 0.850.32 V in the RVA group (P¼0.005). Im-
pedances in the DHBP group were468.4348.83U while impedances
in RVA group were 600.2794.72U (P¼0.06). R wave amplitude was
6.543.0mV in the DHBP group compared with 12.225.20mV in the
RVA group (P¼0.03). No dislodgement or other complications were
found in either group.
CONCLUSIONS Pacing parameters during direct his bundle pacing
were as stable as conventional right ventricular apical pacing. Direct His
bundle pacing can be an option of selective pacing site superior to RVA.
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OBJECTIVES To investigate the percentage of ventricular pacing (%
VP) in atrioventricular block (AVB) and analyze the risk factors which
may affect %VP, with the aim of providing guidance for electrophys-
iologists when programming pacemaker.
METHODS A total of 228 consecutive patients with atrioventricular
block indicated for pacemaker implantation were enrolled in Peking
Union Medical College Hospital between January 2006 and September
2014. Clinical characteristics and programming data were analyzed.
RESULTS There were 125 males and 103 females. The mean age was
68.2114.45 years. The median time of follow-up was 24 months. One
hundred and twenty-three patients (53.94%) were pacing dependent
(%VP99%). Patients with complete AVB were more likely to be
pacing dependent compared to the patients with second degree AVB
(59.06% vs 47.52%, P<0.05). Patients with persistent AVB were more
likely to be pacing dependent compared to the patients with second
degree AVB(60.37% vs 37.50%, P<0.05). Patients without heart failure
were more likely to be pacing dependent compared to the patients
with heart failure(57.61% vs 38.64%, P<0.05). Sex, age, course of
disease, hypertension, coronary heart disease, hyperlipidemia, dia-
betes, beta-blockers, calcium channel blockers, ACE inhibitors and
angiotensin receptor blockers seemed to be no signiﬁcant relationship
with %VP. Thirty-three of 96 patients (34.38%) with persistent com-
plete AVB were not pacing dependent, and 47 of 101 patients (47.5%)
with second degree AVB were pacing dependent.
CONCLUSIONS Patients with persistent and complete AVB as well as
without heart failure were more likely to be pacing dependent. The AV
node function seems to partly recover in some patients with complete
AVB, while some patients with second degree AVB will progress to
complete AVB, which will provide guidance for electrophysiologists
when programming pacemaker on AV search algorithm.
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OBJECTIVES Cardiac resynchronization therapy (CRT) has become an
effective method to treat refractory heart failure, but the long -term
prognosis remains a clinical challenge. This study investigated
whether QT corrected dispersion (QTcD) could be considered to be an
independent marker of prognosis after CRT implantation.
METHODS We stratiﬁed 44 patients receiving CRT into two groups on
the estimation of QTcD, that is, QTcD>60 ms and QTcD60 ms. In all
patients were performed New York Heart Association (NYHA) class
determination, Pro-BNP level, QTcD and QRS measurements, and
complete echocardiographic assessment at the 1,3,6,12 and 18 months
after pacemaker implantation. The end point was prospectively
deﬁned as rehospitalization and cardiac mortality.
RESULTS At baseline, the 1st, 3rd, 6th after implantation, there were
no signiﬁcant differences in NYHA class determination, pro-BNP, QRS
duration and echocardiographic parameters between the two groups(P>0.05). However, after 12 and 18-months follow-up, there had sig-
niﬁcant differences in left ventricular ejection fraction (LVEF), LV
end-diastolic diameter (LVEDd), pro-BNP (P<0.05). Moreover, reho-
spitalization and cardiac mortality were signiﬁcantly decreased in the
patients with QTcD<60 ms.
CONCLUSIONS The results reveal that the CRT patients with
QTcD<60 ms have a better long-term prognosis and QTcD should be
an independent factor of prognosis after CRT implantation.
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OBJECTIVES Ivabradine is an inhibitor of mixed Naþ-Kþ current that
could combine with HCN channels to reduce the transmembrane ve-
locity of funny current (If), heart rate, and cardiac efﬁciency, and thus
be used for the treatment of cardiovascular diseases such as chronic
heart failure. As an ion channel blocker, Ivabradine is also a potential
anti-arrhythmic agent. To explore the effects of Ivabradine on the
electrophysiological parameters in a dog model of age-related atrial
ﬁbrillation (AF), and investigate the underlying mechanisms.
METHODS Aged Beagle dogs underwent rapid atrial pacing for two
months to induce age-related AF in this study. The dogs were
randomly divided into the Ivabradine group and control group. The
effects of Ivabradine on the electrophysiological parameters,
including the effective refractory period of the pulmonary veins and
atrium, duration of AF, and inducing rate of AF, were investigated.
RESULTS As compared to the control group, the ERPs of the left su-
perior pulmonary vein (139.004.18 ms vs 129.004.08 ms, P ¼0.005)
and left auricle (135.003.53 ms vs 122.004.47 ms, P ¼0.001) were
signiﬁcantly increased, while the duration of AF (46.605.07 s vs
205.401.14 s, P ¼0.001) and inducing rate of AF (25% vs 60%,
P ¼0.001) were signiﬁcantly decreased.
CONCLUSIONS Ivabradine could effectively reduce the inducing rate
of AF, and thus be used as an upstream drug for the prevention of age-
related AF.
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Yunfei Feng, Lin Liu, Donghui Yang
The 2nd Hospital of Jilin University (Changchun, 130041)
OBJECTIVES To assess the incidence of new onset rapid atrial ar-
rhythmias (RAT) in sick sinus syndrome (SSS) or high-degree atrio-
ventricular block (AVB) patients with permanent pacemakers, and
investigate the inﬂuence factors of new onset RAT in patients with
permanent pacemaker.
METHODS We collected the hospitalized SSS or high-degree AVB pa-
tients with permanent pacemakers from January 1, 2011 to December
30, 2012 in the Department of Cardiology of the 2nd Hospital of Jilin
University. The data were collected from the medical history and the
follow-up records. Mean follow-up duration is 369 months.
A retrospective study was performed on 180 eligible patients. All the
pacemakers were ﬁrst implanted and in accordance with the class I and
IIa indication. We recorded the detailed demographic and clinical
characteristics, including gender, age, smoking, drinking, coronary
heart disease, hypertension and diabetes, lipids level, heart function,
prescription of angiotensin-converting enzyme inhibitor (ACEI) /
angiotensin II receptor blocker (ARB) and statin, the size of left atrium
(LA) before pacemaker implantation, pacing mode (VVI pacing mode,
non -VVI pacing mode), indication for pacemaker implantation (SSS/
AVB). The endpoint was the occurrence of new onset RAT. All statistical
analyseswere carried out using SPSS 18.0. Single logistic regressionwas
used to analyze the association of considered inﬂuences with RAT.
The signiﬁcant variables (P<0.05) in single logistic regression (unad-
justed logistic regression) were considered for multivariable logistic
regression analysis. We used odds ratio (OR) with 95% conﬁdence in-
terval (CI) and p values to describe the results of logistic regression.
RESULTS There were 48 patients (26.7%) developed atrial tachyar-
rhythmia, including 9 cases (5%) with AT, 3 cases (1.7%) with AFL, 36
cases (20%) with AF. The other patients did not developed RAT during
follow-up. Univariate logistic regression analysis indicated that
